Shares of Modernas (NASDAQ: MRNA) jumped 7% on Wednesday, enhancing the biotechs torrid gains– of more than 315%– so far in 2020..
On Tuesday, a peer-reviewed interim analysis of Modernas phas … [+1470 chars]
Moderna Stock Soars on Promising Coronavirus Vaccine Trial News – Motley Fool